BR9911943A - Compositions comprising gaba analogs and a decongestant to relieve bell headache - Google Patents
Compositions comprising gaba analogs and a decongestant to relieve bell headacheInfo
- Publication number
- BR9911943A BR9911943A BR9911943-9A BR9911943A BR9911943A BR 9911943 A BR9911943 A BR 9911943A BR 9911943 A BR9911943 A BR 9911943A BR 9911943 A BR9911943 A BR 9911943A
- Authority
- BR
- Brazil
- Prior art keywords
- bell
- headache
- decongestant
- relieve
- compositions
- Prior art date
Links
- 206010019233 Headaches Diseases 0.000 title abstract 3
- 231100000869 headache Toxicity 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000000850 decongestant Substances 0.000 title abstract 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical class NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Patente de Invenção: <B>"COMPOSIçõES COMPREENDENDO ANáLOGOS GABA E UM DESCONGESTIONANTE PARA ALIVIAR DOR DE CABEçA DE SINO"<D>. Esta invenção é uma composição e processo para tratamento de dor de cabeça de sino ou dor de sino incluindo análogos de ácido glutâmico e ácido gama amino butírico em combinação com um descongestionante.Invention Patent: <B> "COMPOSITIONS UNDERSTANDING GABA ANALOGS AND A DECONGESTIONANT TO RELIEVE BELL'S HEADACHE" <D>. This invention is a composition and process for treating bell headache or bell pain including analogs of glutamic acid and gamma amino butyric acid in combination with a decongestant.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9214698P | 1998-07-09 | 1998-07-09 | |
| PCT/US1999/013946 WO2000002545A2 (en) | 1998-07-09 | 1999-06-18 | Compositions comprising gaba analogs and a decongestant to relieve sinus headache pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9911943A true BR9911943A (en) | 2001-05-29 |
Family
ID=22231857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9911943-9A BR9911943A (en) | 1998-07-09 | 1999-06-18 | Compositions comprising gaba analogs and a decongestant to relieve bell headache |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1093365A2 (en) |
| JP (1) | JP2002520276A (en) |
| KR (1) | KR20010074682A (en) |
| AU (1) | AU758103B2 (en) |
| BR (1) | BR9911943A (en) |
| CA (1) | CA2332927A1 (en) |
| ID (1) | ID28972A (en) |
| NO (1) | NO20010118D0 (en) |
| NZ (1) | NZ508491A (en) |
| PL (1) | PL345703A1 (en) |
| WO (1) | WO2000002545A2 (en) |
| ZA (1) | ZA200007170B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10048714A1 (en) * | 2000-09-30 | 2002-04-11 | Gruenenthal Gmbh | 5-amino-1-penlen-3-ol derivatives |
| EP1471909A4 (en) * | 2002-01-16 | 2007-07-25 | Endo Pharmaceuticals Inc | Pharmaceutical composition and method for treating disorders of the central nervous system |
| MX2007002790A (en) * | 2004-09-07 | 2007-04-23 | Pfizer | Combination of a 5-ht(1) receptor agonist and an alpha-2-delta ligand for the treatment of migraine. |
| JP2010088301A (en) | 2007-02-01 | 2010-04-22 | Ajinomoto Co Inc | Method for production of l-amino acid |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU1801483C (en) * | 1990-03-19 | 1993-03-15 | Волгоградский государственный медицинский институт | Composition showing hypertension effect |
| US5478565A (en) * | 1990-03-27 | 1995-12-26 | Warner-Lambert Company | Treatment of sinus headache |
| US5604260A (en) * | 1992-12-11 | 1997-02-18 | Merck Frosst Canada Inc. | 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
| AU714980B2 (en) * | 1996-07-24 | 2000-01-13 | Warner-Lambert Company Llc | Isobutylgaba and its derivatives for the treatment of pain |
-
1999
- 1999-06-18 KR KR1020017000259A patent/KR20010074682A/en not_active Ceased
- 1999-06-18 PL PL99345703A patent/PL345703A1/en unknown
- 1999-06-18 CA CA002332927A patent/CA2332927A1/en not_active Abandoned
- 1999-06-18 ID IDW20010055A patent/ID28972A/en unknown
- 1999-06-18 EP EP99928815A patent/EP1093365A2/en not_active Withdrawn
- 1999-06-18 JP JP2000558805A patent/JP2002520276A/en active Pending
- 1999-06-18 BR BR9911943-9A patent/BR9911943A/en not_active IP Right Cessation
- 1999-06-18 NZ NZ508491A patent/NZ508491A/en unknown
- 1999-06-18 AU AU45799/99A patent/AU758103B2/en not_active Ceased
- 1999-06-18 WO PCT/US1999/013946 patent/WO2000002545A2/en not_active Ceased
-
2000
- 2000-12-04 ZA ZA200007170A patent/ZA200007170B/en unknown
-
2001
- 2001-01-08 NO NO20010118A patent/NO20010118D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1093365A2 (en) | 2001-04-25 |
| NZ508491A (en) | 2003-09-26 |
| JP2002520276A (en) | 2002-07-09 |
| NO20010118L (en) | 2001-01-08 |
| ZA200007170B (en) | 2002-03-04 |
| WO2000002545A2 (en) | 2000-01-20 |
| NO20010118D0 (en) | 2001-01-08 |
| KR20010074682A (en) | 2001-08-09 |
| CA2332927A1 (en) | 2000-01-20 |
| AU758103B2 (en) | 2003-03-13 |
| AU4579999A (en) | 2000-02-01 |
| WO2000002545A3 (en) | 2000-04-13 |
| PL345703A1 (en) | 2002-01-02 |
| ID28972A (en) | 2001-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9914051A (en) | Methods for administering antibiotics | |
| BR9911887A (en) | Method for treating insomnia | |
| BR9712824A (en) | Ophthalmic composition of neurotrophic factor, treatment agent for functional optic nerve disorder and method for treating functional optic nerve disorder | |
| BRPI9710372B8 (en) | compound, and, pharmaceutical composition. | |
| FI954654A7 (en) | Amino sugar and glycosaminoglycan composition for the treatment and repair of connective tissue injuries | |
| BR9814282A (en) | "compositions and methods for treating attention deficit disorder and attention deficit / hyperactivity disorder with methylphenidate" | |
| BR9812134A (en) | Pharmaceutical composition for the treatment of dysmenorrhea and premature birth | |
| BR9813028A (en) | Prostaglandin agonists and their use to treat bone disorders | |
| EP1201241B8 (en) | Compositions containing capsaicin or capsaicin analogues and an anesthetic | |
| BR9713465A (en) | Cytically substituted amine metallotprotease inhibitors | |
| ATE234090T1 (en) | COMBINATION OF DULOXETINE WITH NON-STEROID ANTI-INFLAMMATORY DRUGS FOR THE TREATMENT OF PAIN | |
| DE69722426D1 (en) | ISOBUTYLGABA AND ITS DERIVATIVES FOR THE TREATMENT OF PAIN | |
| EP1007556A4 (en) | TROPONIN SUBUNITS AND FRAGMENTS USEFUL AS ANGIOGENESIS INHIBITORS | |
| BR9812484A (en) | Combination therapy for the eradication of detectable hcv-rna in patients with chronic hepatitis c infection | |
| PT881908E (en) | USE OF FIBROBLASTIC GROWTH FACTORS TO STIMULATE OSSEO GROWTH | |
| BR9809117A (en) | Composition of delayed release gel, process of producing the same, pharmaceutical formulation, and processes of treatment of an indication, a disease, and inflammation with a composition of prolonged release | |
| DE69616375D1 (en) | Non-allosteric GABA A agonists used to treat sleep disorders | |
| BR9812371A (en) | Treatment of conduct disorder | |
| ATE444086T1 (en) | THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING PERIODONTITIS WITH ANTI-INFLAMMATORY AGENTS | |
| BR0015698A (en) | Compositions and methods for treating allergic diseases | |
| DE69802113D1 (en) | COMPOSITIONS FOR INCREASING THE CONCENTRATION AND / OR MOBILITY OF SEED CELLS IN HUMANS | |
| BR0306738A (en) | Process and apparatus for preparing crystalline particles of a substance, population of particles, and, pharmaceutical composition | |
| BR9911917A (en) | Compositions comprising gaba and caffeine analogs | |
| BR9814772A (en) | Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis | |
| BR9809678A (en) | Triptolyte derivatives useful in the treatment of autoimmune diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1922 DE 06/11/2007. |